TransMedics

Clinical trials sponsored by TransMedics, explained in plain language.

TransMedics TMDX NASDAQ

A medical technology company developing organ transplant preservation systems.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Heart transplant breakthrough? OCS device Follow-Up study tracks 5-Year survival Results expected Oct 2026 (estimated)
New device aims to boost heart transplant success Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Terminated 1

Warm lung transport device aims to cut transplant failure

Disease control Not yet recruiting

This study tests a device that keeps donor lungs warm and breathing during transport, instead of putting them on ice. The goal is to reduce severe lung swelling (edema) after transplant, which can lead to failure. About 450 lung transplant patients will take part, with two-thirds…

Sponsor: TransMedics • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

TransMedics

Upcoming readouts

Warm lung transport device aims to cut transplant failure